Survival and mortality in cerebral palsy: observations to the sixth decade from a data linkage study of a total population register and National Death Index

Background Likely duration of survival of children described as having cerebral palsy is of considerable interest to individuals with cerebral palsy, their families, carers, health professionals, health economists and insurers. The aim of this paper is to describe patterns of survival and mortality...

Full description

Saved in:
Bibliographic Details
Published in:BMC neurology Vol. 19; no. 1; pp. 111 - 11
Main Authors: Blair, Eve, Langdon, Katherine, McIntyre, Sarah, Lawrence, David, Watson, Linda
Format: Journal Article
Language:English
Published: London BioMed Central 04.06.2019
BioMed Central Ltd
Springer Nature B.V
BMC
Subjects:
ISSN:1471-2377, 1471-2377
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Background Likely duration of survival of children described as having cerebral palsy is of considerable interest to individuals with cerebral palsy, their families, carers, health professionals, health economists and insurers. The aim of this paper is to describe patterns of survival and mortality to the sixth decade in a geographically defined population of people with cerebral palsy stratified according to the clinical description of their impairments in early childhood. Methods Identifiers of persons born in Western Australia 1956–2011, registered with cerebral palsy on the Western Australian Register of Developmental Anomalies and surviving at least 12 months, were linked to the Australian National Death Index in December 2014. Patterns of mortality were investigated using survival analysis methods. Results Of 3185 eligible persons, 436 (13.7%) had died. Of that sample the 22% with the mildest impairment had survival patterns similar to the general population. Mortality increased with increasing severity of impairment. Of 349 (75%) with available cause of death data, 58.6% were attributed to respiratory causes, including 171 (49%) to pneumonia at a mean age of 14.6 (sd 13.4) years of which 77 (45%) were attributed to aspiration. For the most severely impaired, early childhood mortality increased in succeeding decades of birth cohorts from 1950s to 1990 with 20% dying by 4 years of age in the 1981–1990 birth cohort; it then decreased for subsequent birth cohorts, 20% mortality not being attained until 15 years of age. However by 20 years of age mortality of the most severely impaired born in the 1991–2000 birth cohort exceeded that of all other birth cohorts. Remaining life expectancies by age to 50 years have been estimated for two strata with more severe impairments. Conclusion For 22% of individuals with cerebral palsy with mild impairment survival to 58 years is similar to that of the general population. Since 1990 mortality for those with severe cerebral palsy in Western Australia has tended to shift from childhood to early adulthood.
AbstractList Background Likely duration of survival of children described as having cerebral palsy is of considerable interest to individuals with cerebral palsy, their families, carers, health professionals, health economists and insurers. The aim of this paper is to describe patterns of survival and mortality to the sixth decade in a geographically defined population of people with cerebral palsy stratified according to the clinical description of their impairments in early childhood. Methods Identifiers of persons born in Western Australia 1956–2011, registered with cerebral palsy on the Western Australian Register of Developmental Anomalies and surviving at least 12 months, were linked to the Australian National Death Index in December 2014. Patterns of mortality were investigated using survival analysis methods. Results Of 3185 eligible persons, 436 (13.7%) had died. Of that sample the 22% with the mildest impairment had survival patterns similar to the general population. Mortality increased with increasing severity of impairment. Of 349 (75%) with available cause of death data, 58.6% were attributed to respiratory causes, including 171 (49%) to pneumonia at a mean age of 14.6 (sd 13.4) years of which 77 (45%) were attributed to aspiration. For the most severely impaired, early childhood mortality increased in succeeding decades of birth cohorts from 1950s to 1990 with 20% dying by 4 years of age in the 1981–1990 birth cohort; it then decreased for subsequent birth cohorts, 20% mortality not being attained until 15 years of age. However by 20 years of age mortality of the most severely impaired born in the 1991–2000 birth cohort exceeded that of all other birth cohorts. Remaining life expectancies by age to 50 years have been estimated for two strata with more severe impairments. Conclusion For 22% of individuals with cerebral palsy with mild impairment survival to 58 years is similar to that of the general population. Since 1990 mortality for those with severe cerebral palsy in Western Australia has tended to shift from childhood to early adulthood.
Likely duration of survival of children described as having cerebral palsy is of considerable interest to individuals with cerebral palsy, their families, carers, health professionals, health economists and insurers. The aim of this paper is to describe patterns of survival and mortality to the sixth decade in a geographically defined population of people with cerebral palsy stratified according to the clinical description of their impairments in early childhood. Identifiers of persons born in Western Australia 1956-2011, registered with cerebral palsy on the Western Australian Register of Developmental Anomalies and surviving at least 12 months, were linked to the Australian National Death Index in December 2014. Patterns of mortality were investigated using survival analysis methods. Of 3185 eligible persons, 436 (13.7%) had died. Of that sample the 22% with the mildest impairment had survival patterns similar to the general population. Mortality increased with increasing severity of impairment. Of 349 (75%) with available cause of death data, 58.6% were attributed to respiratory causes, including 171 (49%) to pneumonia at a mean age of 14.6 (sd 13.4) years of which 77 (45%) were attributed to aspiration. For 22% of individuals with cerebral palsy with mild impairment survival to 58 years is similar to that of the general population. Since 1990 mortality for those with severe cerebral palsy in Western Australia has tended to shift from childhood to early adulthood.
Likely duration of survival of children described as having cerebral palsy is of considerable interest to individuals with cerebral palsy, their families, carers, health professionals, health economists and insurers. The aim of this paper is to describe patterns of survival and mortality to the sixth decade in a geographically defined population of people with cerebral palsy stratified according to the clinical description of their impairments in early childhood.BACKGROUNDLikely duration of survival of children described as having cerebral palsy is of considerable interest to individuals with cerebral palsy, their families, carers, health professionals, health economists and insurers. The aim of this paper is to describe patterns of survival and mortality to the sixth decade in a geographically defined population of people with cerebral palsy stratified according to the clinical description of their impairments in early childhood.Identifiers of persons born in Western Australia 1956-2011, registered with cerebral palsy on the Western Australian Register of Developmental Anomalies and surviving at least 12 months, were linked to the Australian National Death Index in December 2014. Patterns of mortality were investigated using survival analysis methods.METHODSIdentifiers of persons born in Western Australia 1956-2011, registered with cerebral palsy on the Western Australian Register of Developmental Anomalies and surviving at least 12 months, were linked to the Australian National Death Index in December 2014. Patterns of mortality were investigated using survival analysis methods.Of 3185 eligible persons, 436 (13.7%) had died. Of that sample the 22% with the mildest impairment had survival patterns similar to the general population. Mortality increased with increasing severity of impairment. Of 349 (75%) with available cause of death data, 58.6% were attributed to respiratory causes, including 171 (49%) to pneumonia at a mean age of 14.6 (sd 13.4) years of which 77 (45%) were attributed to aspiration. For the most severely impaired, early childhood mortality increased in succeeding decades of birth cohorts from 1950s to 1990 with 20% dying by 4 years of age in the 1981-1990 birth cohort; it then decreased for subsequent birth cohorts, 20% mortality not being attained until 15 years of age. However by 20 years of age mortality of the most severely impaired born in the 1991-2000 birth cohort exceeded that of all other birth cohorts. Remaining life expectancies by age to 50 years have been estimated for two strata with more severe impairments.RESULTSOf 3185 eligible persons, 436 (13.7%) had died. Of that sample the 22% with the mildest impairment had survival patterns similar to the general population. Mortality increased with increasing severity of impairment. Of 349 (75%) with available cause of death data, 58.6% were attributed to respiratory causes, including 171 (49%) to pneumonia at a mean age of 14.6 (sd 13.4) years of which 77 (45%) were attributed to aspiration. For the most severely impaired, early childhood mortality increased in succeeding decades of birth cohorts from 1950s to 1990 with 20% dying by 4 years of age in the 1981-1990 birth cohort; it then decreased for subsequent birth cohorts, 20% mortality not being attained until 15 years of age. However by 20 years of age mortality of the most severely impaired born in the 1991-2000 birth cohort exceeded that of all other birth cohorts. Remaining life expectancies by age to 50 years have been estimated for two strata with more severe impairments.For 22% of individuals with cerebral palsy with mild impairment survival to 58 years is similar to that of the general population. Since 1990 mortality for those with severe cerebral palsy in Western Australia has tended to shift from childhood to early adulthood.CONCLUSIONFor 22% of individuals with cerebral palsy with mild impairment survival to 58 years is similar to that of the general population. Since 1990 mortality for those with severe cerebral palsy in Western Australia has tended to shift from childhood to early adulthood.
Likely duration of survival of children described as having cerebral palsy is of considerable interest to individuals with cerebral palsy, their families, carers, health professionals, health economists and insurers. The aim of this paper is to describe patterns of survival and mortality to the sixth decade in a geographically defined population of people with cerebral palsy stratified according to the clinical description of their impairments in early childhood. Identifiers of persons born in Western Australia 1956-2011, registered with cerebral palsy on the Western Australian Register of Developmental Anomalies and surviving at least 12 months, were linked to the Australian National Death Index in December 2014. Patterns of mortality were investigated using survival analysis methods. Of 3185 eligible persons, 436 (13.7%) had died. Of that sample the 22% with the mildest impairment had survival patterns similar to the general population. Mortality increased with increasing severity of impairment. Of 349 (75%) with available cause of death data, 58.6% were attributed to respiratory causes, including 171 (49%) to pneumonia at a mean age of 14.6 (sd 13.4) years of which 77 (45%) were attributed to aspiration. For the most severely impaired, early childhood mortality increased in succeeding decades of birth cohorts from 1950s to 1990 with 20% dying by 4 years of age in the 1981-1990 birth cohort; it then decreased for subsequent birth cohorts, 20% mortality not being attained until 15 years of age. However by 20 years of age mortality of the most severely impaired born in the 1991-2000 birth cohort exceeded that of all other birth cohorts. Remaining life expectancies by age to 50 years have been estimated for two strata with more severe impairments. For 22% of individuals with cerebral palsy with mild impairment survival to 58 years is similar to that of the general population. Since 1990 mortality for those with severe cerebral palsy in Western Australia has tended to shift from childhood to early adulthood.
Background Likely duration of survival of children described as having cerebral palsy is of considerable interest to individuals with cerebral palsy, their families, carers, health professionals, health economists and insurers. The aim of this paper is to describe patterns of survival and mortality to the sixth decade in a geographically defined population of people with cerebral palsy stratified according to the clinical description of their impairments in early childhood. Methods Identifiers of persons born in Western Australia 1956–2011, registered with cerebral palsy on the Western Australian Register of Developmental Anomalies and surviving at least 12 months, were linked to the Australian National Death Index in December 2014. Patterns of mortality were investigated using survival analysis methods. Results Of 3185 eligible persons, 436 (13.7%) had died. Of that sample the 22% with the mildest impairment had survival patterns similar to the general population. Mortality increased with increasing severity of impairment. Of 349 (75%) with available cause of death data, 58.6% were attributed to respiratory causes, including 171 (49%) to pneumonia at a mean age of 14.6 (sd 13.4) years of which 77 (45%) were attributed to aspiration. For the most severely impaired, early childhood mortality increased in succeeding decades of birth cohorts from 1950s to 1990 with 20% dying by 4 years of age in the 1981–1990 birth cohort; it then decreased for subsequent birth cohorts, 20% mortality not being attained until 15 years of age. However by 20 years of age mortality of the most severely impaired born in the 1991–2000 birth cohort exceeded that of all other birth cohorts. Remaining life expectancies by age to 50 years have been estimated for two strata with more severe impairments. Conclusion For 22% of individuals with cerebral palsy with mild impairment survival to 58 years is similar to that of the general population. Since 1990 mortality for those with severe cerebral palsy in Western Australia has tended to shift from childhood to early adulthood.
Abstract Background Likely duration of survival of children described as having cerebral palsy is of considerable interest to individuals with cerebral palsy, their families, carers, health professionals, health economists and insurers. The aim of this paper is to describe patterns of survival and mortality to the sixth decade in a geographically defined population of people with cerebral palsy stratified according to the clinical description of their impairments in early childhood. Methods Identifiers of persons born in Western Australia 1956–2011, registered with cerebral palsy on the Western Australian Register of Developmental Anomalies and surviving at least 12 months, were linked to the Australian National Death Index in December 2014. Patterns of mortality were investigated using survival analysis methods. Results Of 3185 eligible persons, 436 (13.7%) had died. Of that sample the 22% with the mildest impairment had survival patterns similar to the general population. Mortality increased with increasing severity of impairment. Of 349 (75%) with available cause of death data, 58.6% were attributed to respiratory causes, including 171 (49%) to pneumonia at a mean age of 14.6 (sd 13.4) years of which 77 (45%) were attributed to aspiration. For the most severely impaired, early childhood mortality increased in succeeding decades of birth cohorts from 1950s to 1990 with 20% dying by 4 years of age in the 1981–1990 birth cohort; it then decreased for subsequent birth cohorts, 20% mortality not being attained until 15 years of age. However by 20 years of age mortality of the most severely impaired born in the 1991–2000 birth cohort exceeded that of all other birth cohorts. Remaining life expectancies by age to 50 years have been estimated for two strata with more severe impairments. Conclusion For 22% of individuals with cerebral palsy with mild impairment survival to 58 years is similar to that of the general population. Since 1990 mortality for those with severe cerebral palsy in Western Australia has tended to shift from childhood to early adulthood.
Background Likely duration of survival of children described as having cerebral palsy is of considerable interest to individuals with cerebral palsy, their families, carers, health professionals, health economists and insurers. The aim of this paper is to describe patterns of survival and mortality to the sixth decade in a geographically defined population of people with cerebral palsy stratified according to the clinical description of their impairments in early childhood. Methods Identifiers of persons born in Western Australia 1956-2011, registered with cerebral palsy on the Western Australian Register of Developmental Anomalies and surviving at least 12 months, were linked to the Australian National Death Index in December 2014. Patterns of mortality were investigated using survival analysis methods. Results Of 3185 eligible persons, 436 (13.7%) had died. Of that sample the 22% with the mildest impairment had survival patterns similar to the general population. Mortality increased with increasing severity of impairment. Of 349 (75%) with available cause of death data, 58.6% were attributed to respiratory causes, including 171 (49%) to pneumonia at a mean age of 14.6 (sd 13.4) years of which 77 (45%) were attributed to aspiration. For the most severely impaired, early childhood mortality increased in succeeding decades of birth cohorts from 1950s to 1990 with 20% dying by 4 years of age in the 1981-1990 birth cohort; it then decreased for subsequent birth cohorts, 20% mortality not being attained until 15 years of age. However by 20 years of age mortality of the most severely impaired born in the 1991-2000 birth cohort exceeded that of all other birth cohorts. Remaining life expectancies by age to 50 years have been estimated for two strata with more severe impairments. Conclusion For 22% of individuals with cerebral palsy with mild impairment survival to 58 years is similar to that of the general population. Since 1990 mortality for those with severe cerebral palsy in Western Australia has tended to shift from childhood to early adulthood. Keywords: Cerebral palsy, Data linkage, Survival, Life expectancy, Time trends, Total population, Western Australia
ArticleNumber 111
Audience Academic
Author Blair, Eve
Watson, Linda
Langdon, Katherine
Lawrence, David
McIntyre, Sarah
Author_xml – sequence: 1
  givenname: Eve
  orcidid: 0000-0002-1443-0859
  surname: Blair
  fullname: Blair, Eve
  email: eve.blair@telethonkids.org.au
  organization: Telethon Kids Institute, University of Western Australia
– sequence: 2
  givenname: Katherine
  surname: Langdon
  fullname: Langdon, Katherine
  organization: Department of Paediatric Rehabilitation, Perth Children’s Hospital
– sequence: 3
  givenname: Sarah
  surname: McIntyre
  fullname: McIntyre, Sarah
  organization: Telethon Kids Institute, Cerebral Palsy Alliance, University of Sydney
– sequence: 4
  givenname: David
  surname: Lawrence
  fullname: Lawrence, David
  organization: Graduate School of Education, University of Western Australia
– sequence: 5
  givenname: Linda
  surname: Watson
  fullname: Watson, Linda
  organization: WA Register of Developmental Anomalies, King Edward Memorial Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31164086$$D View this record in MEDLINE/PubMed
BookMark eNp9kstu1DAUhiNURNuBB2CDLLFhk-JL4gsLpKrcRqpgAawtx3YyLkk82M6o8y48LM5MSzsVsImj3__5js7xf1ocjX60RfEcwTOEOH0dEeaclBCJEpGKlOhRcYIqhkpMGDu6939cnMZ4BSFivEJPimOCEK0gpyfFr69T2LiN6oEaDRh8SKp3aQvcCLQNtgn5Zq36uH0DfBNt2Kjk_BhB8iCtLIjuOq2AsVoZC9rgB6CAUUmB3o0_VJcNaTJb4NusJ59mmF9P_Q4Cgu1cTDbsWn_eadnwzqqMXI7GXj8tHre5t312cy6K7x_ef7v4VF5--bi8OL8sNYUklVRpjjVDqK2FZrRmGiJTC0YoNIIKC21WqTDUKE5x0zSigQpqoYmgSAlOFsVyzzVeXcl1cIMKW-mVkzvBh06qkJzureQNs5hQVWGeNw4pb1FdQag5VKYysM6st3vWemoGa7QdU97hAfTwZnQr2fmNpHUlMBUZ8OoGEPzPycYkBxe17Xs1Wj9FiXFNMMeMzNaXD6xXfgp5ibOrIoRWBPE7V6fyAG5sfe6rZ6g8rwVkmNE8yqI4-4tLzQ87OJ1z17qsHxS8uD_onwlvs5UNbG_QwccYbCu1S7tXzmTXSwTlnGK5T7HMKZZzivNnUaAHlbfw_9XgfU3M3rGz4W4X_y76DZCRA5I
CitedBy_id crossref_primary_10_1111_dmcn_14444
crossref_primary_10_14423_SMJ_0000000000001328
crossref_primary_10_1016_j_bonr_2022_101613
crossref_primary_10_1155_2024_8368191
crossref_primary_10_1017_S0963180122000494
crossref_primary_10_1186_s12891_022_05110_5
crossref_primary_10_3389_fped_2025_1567221
crossref_primary_10_1080_01942638_2024_2419642
crossref_primary_10_1177_23780231251335191
crossref_primary_10_3389_fneur_2021_659031
crossref_primary_10_1002_nur_70000
crossref_primary_10_3389_fped_2021_668544
crossref_primary_10_1016_j_rmed_2021_106443
crossref_primary_10_1016_j_jpurol_2025_07_007
crossref_primary_10_1136_bmjopen_2020_044614
crossref_primary_10_3389_fped_2020_00333
crossref_primary_10_1111_dmcn_15778
crossref_primary_10_1038_s41390_024_03056_z
crossref_primary_10_2340_jrm_v57_43295
crossref_primary_10_3390_biomedicines10123290
crossref_primary_10_1111_dmcn_15120
crossref_primary_10_1007_s41669_021_00299_y
crossref_primary_10_1111_jir_12900
crossref_primary_10_1016_j_spen_2025_101225
crossref_primary_10_1136_bmjopen_2023_076619
crossref_primary_10_1080_17476348_2023_2192483
crossref_primary_10_1080_17518423_2024_2374959
crossref_primary_10_3390_jcm12134548
crossref_primary_10_1007_s00431_021_04219_4
crossref_primary_10_3390_ijerph18189932
crossref_primary_10_1016_j_dhjo_2025_101911
crossref_primary_10_1136_bmjopen_2020_043658
crossref_primary_10_1016_j_jpeds_2024_114435
crossref_primary_10_1111_dmcn_15526
crossref_primary_10_1016_j_amepre_2024_01_011
crossref_primary_10_1007_s13668_023_00485_w
crossref_primary_10_7759_cureus_69071
crossref_primary_10_1016_j_pedneo_2021_01_016
crossref_primary_10_1007_s00455_020_10141_y
crossref_primary_10_1016_j_ejpn_2024_05_015
crossref_primary_10_1111_ppe_12950
crossref_primary_10_1056_NEJMp2403366
crossref_primary_10_1111_dmcn_16281
crossref_primary_10_3390_jcm12041651
crossref_primary_10_1080_01924788_2024_2317054
crossref_primary_10_15446_rsap_v26n5_110915
crossref_primary_10_1016_j_jpedsurg_2021_05_021
crossref_primary_10_1007_s43032_023_01422_6
crossref_primary_10_3390_jcm12165238
crossref_primary_10_1186_s12903_023_02867_6
crossref_primary_10_1515_teb_2025_0007
crossref_primary_10_1007_s00464_024_11224_9
crossref_primary_10_7759_cureus_39327
crossref_primary_10_1097_MD_0000000000026269
crossref_primary_10_1002_pmrj_13277
crossref_primary_10_7759_cureus_36174
crossref_primary_10_3389_fneur_2021_732939
crossref_primary_10_3390_children10060994
crossref_primary_10_3390_nu16152394
crossref_primary_10_3390_ijns9020030
crossref_primary_10_3390_jpm11070604
crossref_primary_10_1111_dmcn_14640
crossref_primary_10_1016_j_anpede_2021_07_002
crossref_primary_10_1016_S0140_6736_20_32340_0
crossref_primary_10_3390_jcm13133759
crossref_primary_10_1016_j_cell_2020_08_050
crossref_primary_10_3390_jcm10081676
crossref_primary_10_1111_jep_70011
crossref_primary_10_1111_ppe_13024
crossref_primary_10_1016_j_sjbs_2021_12_026
crossref_primary_10_2196_51606
crossref_primary_10_1038_s41598_024_61375_x
crossref_primary_10_1016_j_physio_2025_101816
crossref_primary_10_1136_bmjopen_2020_041425
crossref_primary_10_1016_j_anpedi_2021_07_011
crossref_primary_10_3390_jcm11236968
crossref_primary_10_1136_bmjopen_2019_035892
crossref_primary_10_1111_dmcn_14871
crossref_primary_10_3233_WOR_220705
crossref_primary_10_1111_dmcn_15841
crossref_primary_10_1016_S0140_6736_25_00686_5
crossref_primary_10_3390_jcm13030888
crossref_primary_10_3390_medicina59101841
crossref_primary_10_1111_jhn_13277
crossref_primary_10_1016_j_apmr_2021_12_003
crossref_primary_10_1055_s_0044_1787994
crossref_primary_10_3390_ijerph19116602
crossref_primary_10_1111_dmcn_14759
crossref_primary_10_1111_dmcn_15568
crossref_primary_10_1111_dmcn_14860
crossref_primary_10_2147_CLEP_S294202
crossref_primary_10_1136_bmjopen_2020_042652
crossref_primary_10_1016_j_pediatrneurol_2022_12_004
crossref_primary_10_1007_s12325_023_02689_6
crossref_primary_10_1097_PEP_0000000000001092
crossref_primary_10_5114_pq_2023_125166
crossref_primary_10_1186_s12887_021_02945_0
crossref_primary_10_1016_j_rmed_2024_107717
crossref_primary_10_1016_j_siny_2020_101137
crossref_primary_10_1007_s11910_020_1022_z
crossref_primary_10_1089_jicm_2021_0158
crossref_primary_10_1016_j_bone_2024_117267
crossref_primary_10_1016_j_arcped_2023_03_006
crossref_primary_10_1002_jcsm_13640
crossref_primary_10_1111_dmcn_15317
crossref_primary_10_1111_dmcn_15714
crossref_primary_10_1097_BPO_0000000000001779
crossref_primary_10_51536_tusbad_1574177
crossref_primary_10_1136_bmjopen_2025_105309
crossref_primary_10_1111_dmcn_16234
crossref_primary_10_1097_PCC_0000000000003253
crossref_primary_10_1111_dmcn_15420
crossref_primary_10_1111_dmcn_15662
crossref_primary_10_1177_18758894251330469
crossref_primary_10_1371_journal_pone_0235069
crossref_primary_10_1016_j_bone_2022_116390
crossref_primary_10_1016_j_ijporl_2025_112226
crossref_primary_10_3390_v16081284
crossref_primary_10_1093_ptj_pzaa152
crossref_primary_10_3390_children10081353
crossref_primary_10_3390_jcm14051572
crossref_primary_10_1097_MD_0000000000023907
crossref_primary_10_1177_21925682231159347
crossref_primary_10_1111_dmcn_15705
crossref_primary_10_1210_endrev_bnab028
crossref_primary_10_1002_ppul_27284
Cites_doi 10.1542/peds.2017-0731
10.1017/S0012162201000949
10.1111/j.1469-8749.1979.tb01691.x
10.1001/jama.2015.11025
10.1136/jech.55.1.38
10.1111/j.1469-8749.2012.04365.x
10.1016/j.apmr.2010.10.002
10.1111/dmcn.12718
10.1111/j.1469-8749.2012.04218.x
10.1111/dmcn.12999
10.1002/ddrr.18
10.1017/S001216229900122X
10.1016/j.clp.2006.03.016
10.1111/dmcn.13350
10.1111/dmcn.12520
10.1017/S0012162201211049
ContentType Journal Article
Copyright The Author(s). 2019
COPYRIGHT 2019 BioMed Central Ltd.
2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s). 2019
– notice: COPYRIGHT 2019 BioMed Central Ltd.
– notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
NPM
3V.
7TK
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12883-019-1343-1
DatabaseName Springer Nature OA Free Journals
CrossRef
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central Database Suite (ProQuest)
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ: Directory of Open Access Journal (DOAJ)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
PubMed
Publicly Available Content Database


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2377
EndPage 11
ExternalDocumentID oai_doaj_org_article_8b7e236a428343068f15400c80ad4d05
PMC6549269
A590727634
31164086
10_1186_s12883_019_1343_1
Genre Journal Article
GeographicLocations Australia
Sweden
Victoria Australia
Western Australia Australia
GeographicLocations_xml – name: Australia
– name: Victoria Australia
– name: Sweden
– name: Western Australia Australia
GrantInformation_xml – fundername: Cerebral Palsy Alliance Research Foundation
  grantid: CDG6616
  funderid: http://dx.doi.org/10.13039/100012256
– fundername: Cerebral Palsy Alliance Research Foundation
  grantid: CDG6616
– fundername: ;
  grantid: CDG6616
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABIVO
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EJD
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IGS
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
AFFHD
CITATION
-A0
3V.
ACRMQ
ADINQ
ALIPV
C24
NPM
7TK
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c603t-6ac82c711f59c7657c01d597360d969e0ec7669d6da862bbb9b0a0c9c3961a983
IEDL.DBID RSV
ISICitedReferencesCount 132
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000470296200002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1471-2377
IngestDate Fri Oct 03 12:46:37 EDT 2025
Tue Nov 04 01:57:05 EST 2025
Wed Oct 01 17:27:16 EDT 2025
Thu Oct 09 21:41:54 EDT 2025
Tue Nov 11 10:07:26 EST 2025
Tue Nov 04 18:02:22 EST 2025
Wed Feb 19 02:35:44 EST 2025
Sat Nov 29 01:39:53 EST 2025
Tue Nov 18 21:53:03 EST 2025
Sat Sep 06 07:35:58 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Cerebral palsy
Western Australia
Life expectancy
Total population
Time trends
Survival
Data linkage
Language English
License Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c603t-6ac82c711f59c7657c01d597360d969e0ec7669d6da862bbb9b0a0c9c3961a983
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
ORCID 0000-0002-1443-0859
OpenAccessLink https://link.springer.com/10.1186/s12883-019-1343-1
PMID 31164086
PQID 2243364318
PQPubID 44772
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_8b7e236a428343068f15400c80ad4d05
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6549269
proquest_miscellaneous_2253282739
proquest_journals_2243364318
gale_infotracmisc_A590727634
gale_infotracacademiconefile_A590727634
pubmed_primary_31164086
crossref_citationtrail_10_1186_s12883_019_1343_1
crossref_primary_10_1186_s12883_019_1343_1
springer_journals_10_1186_s12883_019_1343_1
PublicationCentury 2000
PublicationDate 2019-06-04
PublicationDateYYYYMMDD 2019-06-04
PublicationDate_xml – month: 06
  year: 2019
  text: 2019-06-04
  day: 04
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle BMC neurology
PublicationTitleAbbrev BMC Neurol
PublicationTitleAlternate BMC Neurol
PublicationYear 2019
Publisher BioMed Central
BioMed Central Ltd
Springer Nature B.V
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: Springer Nature B.V
– name: BMC
References S Goldsmith (1343_CR1) 2016; 58
1343_CR9
1343_CR7
KA Benfer (1343_CR19) 2017; 140
M Peterson (1343_CR21) 2015; 314
JL Hutton (1343_CR2) 2006; 33
SM Reid (1343_CR5) 2012; 54
FJ Stanley (1343_CR8) 1979; 21
1343_CR15
JC Brooks (1343_CR6) 2014; 56
RM Shavelle (1343_CR13) 2001; 43
E Meehan (1343_CR16) 2017; 59
1343_CR10
PBS Silcocks (1343_CR11) 2001; 55
DJ Strauss (1343_CR12) 2005; 37
N Young (1343_CR17) 2011; 92
SM Reid (1343_CR14) 2012; 54
K Himmelmann (1343_CR4) 2015; 57
E Blair (1343_CR3) 2001; 43
P Sullivan (1343_CR18) 2008; 14
David Strauss (1343_CR20) 1999; 41
References_xml – ident: 1343_CR10
– volume: 140
  issue: 6
  year: 2017
  ident: 1343_CR19
  publication-title: Pediatrics.
  doi: 10.1542/peds.2017-0731
– volume: 43
  start-page: 508
  year: 2001
  ident: 1343_CR3
  publication-title: Dev Med Child Neurol
  doi: 10.1017/S0012162201000949
– ident: 1343_CR15
– volume: 21
  start-page: 701
  year: 1979
  ident: 1343_CR8
  publication-title: Dev Med Child Neurol
  doi: 10.1111/j.1469-8749.1979.tb01691.x
– volume: 314
  start-page: 2303
  issue: 21
  year: 2015
  ident: 1343_CR21
  publication-title: JAMA
  doi: 10.1001/jama.2015.11025
– volume: 37
  start-page: 20
  year: 2005
  ident: 1343_CR12
  publication-title: J Insur Med
– volume: 55
  start-page: 38
  year: 2001
  ident: 1343_CR11
  publication-title: J Epidemiol Community Health
  doi: 10.1136/jech.55.1.38
– volume: 54
  start-page: 867
  year: 2012
  ident: 1343_CR14
  publication-title: Dev Med Child Neurol
  doi: 10.1111/j.1469-8749.2012.04365.x
– volume: 92
  start-page: 46
  year: 2011
  ident: 1343_CR17
  publication-title: Arch Phys Med Rehabil
  doi: 10.1016/j.apmr.2010.10.002
– volume: 57
  start-page: 762
  year: 2015
  ident: 1343_CR4
  publication-title: Dev Med Child Neurol
  doi: 10.1111/dmcn.12718
– volume: 54
  start-page: 353
  year: 2012
  ident: 1343_CR5
  publication-title: Dev Med Child Neurol
  doi: 10.1111/j.1469-8749.2012.04218.x
– ident: 1343_CR7
– volume: 58
  start-page: 11
  year: 2016
  ident: 1343_CR1
  publication-title: Dev Med Child Neurol
  doi: 10.1111/dmcn.12999
– ident: 1343_CR9
– volume: 14
  start-page: 128
  year: 2008
  ident: 1343_CR18
  publication-title: Dev Disabil Res Rev
  doi: 10.1002/ddrr.18
– volume: 41
  start-page: 580
  issue: 9
  year: 1999
  ident: 1343_CR20
  publication-title: Developmental Medicine & Child Neurology
  doi: 10.1017/S001216229900122X
– volume: 33
  start-page: 545
  year: 2006
  ident: 1343_CR2
  publication-title: Clin Perinatol
  doi: 10.1016/j.clp.2006.03.016
– volume: 59
  start-page: 512
  year: 2017
  ident: 1343_CR16
  publication-title: Dev Med Child Neurol
  doi: 10.1111/dmcn.13350
– volume: 56
  start-page: 1059
  year: 2014
  ident: 1343_CR6
  publication-title: Dev Med Child Neurol
  doi: 10.1111/dmcn.12520
– volume: 43
  start-page: 574
  year: 2001
  ident: 1343_CR13
  publication-title: Dev Med Child Neurol
  doi: 10.1017/S0012162201211049
SSID ssj0017841
Score 2.5481346
Snippet Background Likely duration of survival of children described as having cerebral palsy is of considerable interest to individuals with cerebral palsy, their...
Likely duration of survival of children described as having cerebral palsy is of considerable interest to individuals with cerebral palsy, their families,...
Background Likely duration of survival of children described as having cerebral palsy is of considerable interest to individuals with cerebral palsy, their...
Abstract Background Likely duration of survival of children described as having cerebral palsy is of considerable interest to individuals with cerebral palsy,...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 111
SubjectTerms Age
Births
Caregivers
Cerebral palsied persons
Cerebral palsy
Child neurology
Children
Children & youth
Data linkage
Death
Disability
Economists
Health
Health insurance industry
Insurance companies
Insurance industry
Life expectancy
Medical personnel
Medical records
Medicine
Medicine & Public Health
Mortality
Neurochemistry
Neurology
Neurosurgery
Paralysis
Patient admissions
Pneumonia
Population
Population studies
Research Article
Studies
Surveys
Survival
Time trends
Total population
Young adults
SummonAdditionalLinks – databaseName: DOAJ: Directory of Open Access Journal (DOAJ)
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bi9UwEA6yiPgi3q2uMoIgKIdNekkT39bLoqCL4IV9C2mSsgeO7XLas6z_xR_rTNpTtyvqi69JmiaZS2YyyTeMPcmDKkOq5IKg9tBBURxFKkVnpfR1qJQNRXwh9_V9eXiojo70x3OpvuhO2AAPPCzcnqqwr0xaAgbL0b5VNW76nDvFrc_9gF6Kf9g6U2P8gKJpYwxTKLnXCUqqi26zXoiMMDlnu1AE6_9dJZ_bky7el7wQNI170cF1dm00ImF_GPwNdik0N9mVD2OY_Bb78WmDGgB5CGzj4Vu0sNHahmUDLqwpVLyCE-S77y-graZj2Q76FtAehG551h-DD3R1Huj9CVigm6RA0V7UPxAxaaGtsbxve-psSgMGlOmBwBfir0fU7RW8JksT3hE042325eDN51dvF2MahoWTPOsX0jqVulKIutCulEXpuPDoh2SSey114AFLpfbSW3SPqqrSFbfcaZdpKaxW2R2207RNuMdA1Jn2aUmvZWWu6pI8c1mI2iqP5rOSCeNbshg3YpRTqoyVib6KkmagpEFKGqKkEQl7Nn1yMgB0_K3xS6L11JCwtWMBcpwZOc78i-MS9pQ4xZAGwME5Oz5kwCkSlpbZL3BaKertPGG7s5YouW5eveU1M2qOzqBJhVKDZp1K2OOpmr6k23BNaDfUpsjQVS4znbC7A2tOU8oEOsCclrKcMe1szvOaZnkcccUlofVJ7PP5lr1_DeuPS3r_fyzpA3Y1JeGk0618l-306014yC67037ZrR9F0f4JY49OIw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Publicly Available Content Database
  dbid: PIMPY
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Zb9QwELZgixAv3IVAQUZCQgJFa-dwbF5QOSoq0aoSh8qT5dgOXWlJlk0WwX_hxzKT9aakiD7xajveTHZOz_gbQh5nXhY-kSJGqD0IUCQDkUogWClc5UtpfN7fkPv0rjg8lMfH6ihcj25DWeVGJ_aKeo32jHXboISnrrF4Yj4FwwN7g_GTLxbfYuwhhbnW0FDjItlC4C05IVtH-wdHn4esAubYQmaTSzFtObbahWBaxTxFpM6Rbeoh_P9W1H9YqrNVlGdSqb2F2rv2f2m7Tq4GT5XurlnrBrng65vk8kHIxd8iv96vQM0Ao1JTO_q1d-PBpaezmlq_xHz0nC6AuX8-p005nP22tGsoOJ20nf3oTqjzWJ9P8ZILNRTLVSmmlEHJ0R74ljYVjHdNh5sNvcYotpNAhIf-pwO095y-RneW7iP-423yce_Nh1dv49DrIbaCpV0sjJWJLTivcmULkReWcQfBTiqYU0J55mFUKCecgRisLEtVMsOssqkS3CiZbpNJ3dT-LqG8SpVLCrySKzJZFRj-i5xXRjrw0aWICNv8y9oGIHTsxzHXfUAkhV4zhgbG0MgYmkfk6fDIYo0Cct7il8g6w0IE8O4HmuUXHfSBliWISCoM4t1lELbJCnxZxqxkxmWO5RF5goynUc3Ay1kTbksAiQjYpXdzICsB45BFZGe0EtSDHU9veE4H9dTqUxaLyKNhGp_EkrvaNytck6cQjxepisidNacPJKUcomyGn7IYycCI5vFMPTvpwcsFQgIK2PPZRlpOX-ufn_Te-UTcJ1cSlGI8HMt2yKRbrvwDcsl-72bt8mHQAr8Bh41qnw
  priority: 102
  providerName: ProQuest
Title Survival and mortality in cerebral palsy: observations to the sixth decade from a data linkage study of a total population register and National Death Index
URI https://link.springer.com/article/10.1186/s12883-019-1343-1
https://www.ncbi.nlm.nih.gov/pubmed/31164086
https://www.proquest.com/docview/2243364318
https://www.proquest.com/docview/2253282739
https://pubmed.ncbi.nlm.nih.gov/PMC6549269
https://doaj.org/article/8b7e236a428343068f15400c80ad4d05
Volume 19
WOSCitedRecordID wos000470296200002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVADU
  databaseName: BioMedCentral
  customDbUrl:
  eissn: 1471-2377
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017841
  issn: 1471-2377
  databaseCode: RBZ
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://www.biomedcentral.com/search/
  providerName: BioMedCentral
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1471-2377
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017841
  issn: 1471-2377
  databaseCode: DOA
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1471-2377
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017841
  issn: 1471-2377
  databaseCode: M~E
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1471-2377
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017841
  issn: 1471-2377
  databaseCode: 7X7
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1471-2377
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017841
  issn: 1471-2377
  databaseCode: BENPR
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 1471-2377
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017841
  issn: 1471-2377
  databaseCode: PIMPY
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: SpringerLINK Contemporary 1997-Present
  customDbUrl:
  eissn: 1471-2377
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017841
  issn: 1471-2377
  databaseCode: RSV
  dateStart: 20011201
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwELZoixAv3EegrIyEhARa4Vw-eGuhFZXoatVCVZ4sx3boSktSbbII_gs_lhlvNpBySPASaX1kbWdmPOMZf0PIk8xL4RPJxwi1BwaKZMBSCRgrwpW-kMbn4YbcyVsxmcjTUzXt7nE362j3tUsySOrA1pK_aGJMjAumrxrHKeJqbpAt2O0kcuPR8UnvOkBHWue-_G23wQYUcPp_lcY_bUcXQyUv-EvDNrR__b8mcINc67ROurMik5vkkq9ukSuHnV_9Nvl2vASRAURHTeXop6CSg3pOZxW1foG-5Tk9B0L9-pLWRX-O29C2pqBA0mb2pT2jzmOsPcULK9RQDD2lOEwQWDSA2NK6hPK2bvFlfd4wiqkhEK0h_HUH0z2nr1E1pQeI5XiHvN_fe_fqzbjL2zC2nKXtmBsrEyviuMyVFTwXlsUODJeUM6e48sxDKVeOOwP2VFEUqmCGWWVTxWOjZHqXbFZ15e8TGpepconA67U8k6VAU57ncWmkA31b8oiw9cfUtgM1x9wacx2MG8n1atU1rLrGVddxRJ71Xc5XiB5_a7yLFNI3RDDuUFAvPuqOt7UsgNxTbhC7LgMTTJaglzJmJTMucyyPyFOkL40iAwZnTXfzAaaI4Ft6J4dpJSDos4hsD1oCq9th9ZpCdSdqGg06GLAZ6IEyIo_7auyJ4XOVr5fYJk_Bthapisi9FUH3U0pjsJgZLqUYkPpgzsOaanYWgMg5wvtxeOfzNcH_GNYfl_TBP7V-SK4myDF47pVtk812sfSPyGX7uZ01ixHZEKciPOWIbO3uTaZHo3CqAr-mB4fTD6MgG74DbT5ZTg
linkProvider Springer Nature
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELZKQcCF9yNQwEggJFBUOw_HRkKoUKquuq2QaNHeTGI7dKUlWXazQP8Lv4HfyEw2SUkRvfXANXa8sXeenplvCHkSOZm4QAofofbAQZEMWCoAZyWxuctk6uK6Qu7jMNnbk6ORer9CfrW1MJhW2crEWlDb0uAd-TqoGlgN1J18Pf3qY9cojK62LTSWZLHjjr6DyzZ_NdiE__dpEGy923-77TddBXwjWFj5IjUyMAnneaxMIuLEMG7BrA4Fs0ooxxw8FcoKm4K1n2WZyljKjDKhEjxVMoR1z5HzIMcTTCFLRp2DxzGG10ROuRTrc46tfMFZVz4PEQm0p_vqFgF_K4I_NOHJLM0TodpaA25d_d_O7hq50tjadGPJHNfJiitukIu7TTbBTfLzwwIEJbAaTQtLv9SOCDgldFxQ42YYUZ_QKbDn0UtaZt3t9ZxWJQWzmc7HP6pDah1WGFAs06EpxYRbikFxENO0hu6lZQ7Pq7LCxbpuaRQbYiBGRf3TDTj5hG6iQU4HiGB5ixycydncJqtFWbi7hPI8VDZIsKhYRDJP8AJDxDxPpQUvQwqPsJaOtGmg3LGjyETXLp0Uekl6GkhPI-lp7pHn3SvTJY7JaZPfIHF2ExGCvH5Qzj7rRqJpmQGThyJFxL4IHE-ZgzXOmJEstZFlsUeeIWlrFJTwcSZt6j1giwg5pjdi2FYA6i3yyFpvJgg40x9uqVo3Anauj0naI4-7YXwTkwYLVy5wThwGEuxz5ZE7S17qthRyLkAywVEmPS7r7bk_UowPa_h1gaCGAtZ80fLj8Wf980jvnb6JR-TS9v7uUA8Hezv3yeUAZQZe9UVrZLWaLdwDcsF8q8bz2cNa4lDy6azZ9DeTErlj
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3bbtQwELWgoIoX7oVAgUFCQgKt6twcm7dCqagoq0qFqm-WYzt0pSVZbbII_oWPZSbJBlIuEuLVl8R2ZsZzMvYZxp4kXmY-kmJCVHsIUCRHlYoQrGSu8Lk0Pm1vyJ0cZtOpPD1VR32e03p92n0dkuzuNBBLU9nsLFzRqbgUO3VISXIRBqtJGBPH5kV2KaGcQQTXj0-GMAIF1fpQ5m-7jTajlrP_V8v809Z0_tjkudhpuyXtX_vvyVxnV3tvFHY78bnBLvjyJtt818fbb7Fvxys0JSiMYEoHn1pXHd12mJVg_ZJiznNYoAB_fQFVPvzfraGpAB1LqGdfmjNwns7gA11kAQN0JBVoyGjIoCW3harA8qZq6GFDPjGglBHE4tC-uqfvnsMeuaxwQByPt9mH_dfvX72Z9PkcJlbwuJkIY2VkszAsUmUzkWaWhw4BTSy4U0J57rFUKCecQZyV57nKueFW2ViJ0CgZb7GNsir9XQZhESsXZXTtViSyyAjiizQsjHToh0sRML7-sNr2ZOeUc2OuW9Ajhe5WXeOqa1p1HQbs2dBl0TF9_K3xS5KWoSGRdLcF1fKj7nVeyxzVIBaGOO0ShGayQH-Vcyu5cYnjacCekqxpMiU4OGv6GxE4RSLl0rspTivCDSAJ2PaoJZoAO65eS6vuTVCt0TdD9UP_UAbs8VBNPelYXemrFbVJY8TcWawCdqcT7mFKcYhImtNSZiOxH815XFPOzlqCckG0fwKf-Xwt_D-G9cclvfdPrR-xzaO9fX14MH17n12JSHno11iyzTaa5co_YJft52ZWLx-2BuE7by1fBg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Survival+and+mortality+in+cerebral+palsy%3A+observations+to+the+sixth+decade+from+a+data+linkage+study+of+a+total+population+register+and+National+Death+Index&rft.jtitle=BMC+neurology&rft.au=Blair%2C+Eve&rft.au=Langdon%2C+Katherine&rft.au=McIntyre%2C+Sarah&rft.au=Lawrence%2C+David&rft.date=2019-06-04&rft.issn=1471-2377&rft.eissn=1471-2377&rft.volume=19&rft.issue=1&rft_id=info:doi/10.1186%2Fs12883-019-1343-1&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12883_019_1343_1
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2377&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2377&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2377&client=summon